Scholars Central

Search Scholars Central

Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.

Advanced searchHide advanced search

In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:

Years

1–25 of 760 articles for Random sequence.

Then save them, add them to a collection or cite them together.
  1. Conference abstract

    Bioequivalence and pharmacokinetic comparison between extended release capsules of carvedilol phosphate 40 mg: An open label, balanced, randomized-sequence, single-dose, two-period crossover study in healthy male volunte

    Journal of Bioequivalence & Bioavailability

    open-labeled, balanced, single-dose, two treatment, two period, two sequence, randomized two way crossover study was conducted in 18 healthy adult male subjects to determine the pharmacokinetic, bioavailability

  2. Research article · 2011

    Bioavailability of Two Oral-Suspension Formulations of a Single Dose of Nitazoxanide 500 mg: An Open-Label, Randomized-Sequence, Two-Period Crossover, Comparison in Healthy Fasted Mexican Adult Volunteers

    Journal of Bioequivalence & Bioavailability · Volume 3, Issue 3

    regarding the oral bioavailability of this drug on the Mexican population. This single-dose, randomized-sequence, open-label, 2-period crossover study was conducted on a total of 26 Mexican

  3. Conference abstract · 10 Aug 2015

    Title:Bioequivalence comparison between two different formulations of alverine citrate 120mg capsules: an open label, balanced, randomized-sequence, single-dose, two-period crossover study in healthy male volunteers

    Journal of Pharmaceutical Care & Health Systems

    open-labeled, balanced, single-dose, 2-treatment, 2-period, 2-sequence, randomized crossover study was designed and conducted to determine the pharmacokinetic, bioavailability and bioequivalence of alverine citrate

  4. Research article · 3 May 2019

    Pharmacokinetic and bioequivalence comparison between ursodeoxycholic acid tablets 500mg: An open label, balanced, randomized-sequence, singledose, two-period crossover study in healthy male volunteers

    Der Pharmacia Lettre · Volume 7, Issue 10

    healthy adult male subjects. Therefore the design of an open label, balanced, randomized, two-sequence, single dose, two way crossover study with a wash-out period of at least ... used. An open-labeled, balanced…

  5. Research article · 2016

    Bioequivalence of Ipratropium Bromide HFA pMDI 20 μg/actuation in Healthy Volunteers with and without Charcoal Blockade and with Spacer Device

    Journal of Bioequivalence & Bioavailability · Volume 8, Issue 4

    without charcoal blockade; and with spacer device. Study-1 was single dose, randomized, 4-period, 2‑sequence, laboratory-blinded, crossover, replicate design conducted in 90 healthy volunteers under fasting conditions…

  6. Research article · 15 Feb 2023

    An Open Label, Balanced, Randomized, Two Treatments, Two Sequences, Two Periods, Single Dose, Cross Over, Bioequivalence Study of Bosutinib 100 Mg Tablets of Abbott Laboratories Versus Bosulif (Bosutinib) 100 Mg Film Coated Tablets of Pfizer Limited Under Fed Condition in Healthy Subjects

    Journal of Bioequivalence & Bioavailability · Volume 15, Issue 1

    coated tablets of Pfizer Limited in healthy subjects. An open label, balanced, randomized, two treatments, two sequences, two periods, single dose, cross over study with washout period of 07 days

  7. Research article · 19 Dec 2022

    An Open Label, Balanced, Randomized, Two Treatments, Two Sequences, Four Periods, Fully Replicate, Crossover, Bioequivalence Study of Abiraterone Acetate 250 mg Tablets of Abbott Laboratories De Colombia Versus ZYTIGA® (Abiraterone Acetate) 250 mg Tablets of Janssen Biotech, Inc. Under Fasting Condition in Healthy Subjects

    Journal of Bioequivalence & Bioavailability

    Biotech, Inc. under fasting condition in healthy subjects. An open label, balanced, randomized, two treatments, two sequences, four periods, fully replicate, cross-over single dose study with washout period

  8. Research article · 28 Jun 2023

    An Open Label, Balanced, Randomized, Two Treatments, Three Sequences, Three Periods, Single Dose, Semi-Replicate, Crossover, Oral Bioequivalence Study of Palbociclib 125 Mg Capsules of Abbott Laboratories De Colombia Versus Ibrance (Palbociclib) 125 Mg Capsules of Pfizer in Healthy, Adult, Human Subjects Under Fed Conditions

    Journal of Bioequivalence & Bioavailability · Volume 15, Issue 3

    Capsules of Pfizer in healthy subjects. An open label, balanced, randomized, two treatments, three sequences, three periods, single dose, semi replicate, cross over with washout period of 10 days under

  9. Research article · 31 Jan 2023

    An Open Label, Balanced, Randomized, Two Treatments, Two Sequences, Two Periods, Single Dose, Cross Over, Oral Bioequivalence Study of Vildagliptin 50 Mg Tablets of Abbott Laboratories De Colombia vs. Jalra (Vildagliptin) 50 Mg Tablets of Novartis Pharma Stein Ag, in Healthy, Adult, Human Subjects Under Fasting Condition

    Journal of Bioanalysis & Biomedicine · Volume 15, Issue 1

    Stein AG, in healthy subjects under fasting condition. An open label, balanced, randomized, two treatments, two sequences, two periods, single dose, cross over study with washout period of 03 days

  10. Article · 13 Oct 2023

    An Open Label, Balanced, Randomized, Two Treatments, Two Sequences, Two Periods, Crossover, Single Dose, Bioequivalence Study of Olmesartan medoxomil/Hydrochlorothiazide 20 mg/12.5 mg Coated Tablets of Abbott and Olmetec plusandreg;andnbsp;(Olmesartan medoxomil/Hydrochlorothiazide) 20 mg/12.5 mg Coated Tablets of Daiichi-Sankyo in Healthy, Adult, Human Subjects Under Fasting Condition

    Journal of Bioequivalence & Bioavailability · Volume 15, Issue 5

    Daiichi-Sankyo in healthy, adult, human subjects. An open label, balanced, randomized two treatments, two sequences, two periods, crossover, single dose study with washout period of 02 days under fasting

  11. Research article · 5 Oct 2023

    An Open Label, Balanced, Randomized, Two Treatments, Two Sequences, Two Periods, Crossover, Single Dose, Bioequivalence Study of Olmesartan Medoxomil/Hydrochlorothiazide 40 mg/12.5 mg Coated Tablets of Abbott and Olmetec Plus® (Olmesartan Medoxomil/Hydrochlorothiazide) 40 mg/12.5 mg Coated Tablets of Daiichi-Sankyo in Healthy, Adult, Human Subjects Under Fasting Condition

    Journal of Bioequivalence & Bioavailability · Volume 15, Issue 4

    Daiichi- Sankyo in healthy, adult, human subjects. An open label, balanced, randomized two treatments, two sequences, two periods, crossover, single dose study with washout period of 02 days under fasting

  12. Research article · 5 Oct 2023

    An Open Label, Balanced, Randomized, Two Treatments, Two Sequences, Two Periods, Crossover, Single Dose, Oral Bioequivalence Study of Femelle 20 (Drospirenone 3 Mg and Ethinyl Estradiol 0.02 Mg) Coated Tablets of Abbott and Yaz® (Drospirenone 3 Mg And Ethinyl Estradiol 0.02 Mg) Coated Tablets of Bayer in Healthy, Adult, Human Female Subjects Under Fasting Condition

    Journal of Bioequivalence & Bioavailability · Volume 15, Issue 4

    fasting condition in healthy non-pregnant female subjects. An open label, balanced, randomized, two treatments, two sequences, two periods, crossover, single dose study with washout period of 14 days

  13. Research article · 8 Dec 2015

    Molecular authentication of Gynostemma pentaphyllum through development and application of random amplification polymorphic DNA sequence-characterized amplified region marker

    Genetics and Molecular Research · Volume 14, Issue 4

    identification and authentication of G. pentaphyllum, a combination of random amplification polymorphic DNA (RAPD) technique with sequence-characterized amplified region (SCAR) markers was studied. Twenty-five samples…

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels